DK1140090T3 - Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt - Google Patents

Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt

Info

Publication number
DK1140090T3
DK1140090T3 DK00900025T DK00900025T DK1140090T3 DK 1140090 T3 DK1140090 T3 DK 1140090T3 DK 00900025 T DK00900025 T DK 00900025T DK 00900025 T DK00900025 T DK 00900025T DK 1140090 T3 DK1140090 T3 DK 1140090T3
Authority
DK
Denmark
Prior art keywords
phanquinone
prevention
treatment
memory failure
failure
Prior art date
Application number
DK00900025T
Other languages
English (en)
Inventor
Michel Xilinas
Panayotis Nikolas Gerolymatos
Original Assignee
Gerolymatos P N Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerolymatos P N Sa filed Critical Gerolymatos P N Sa
Application granted granted Critical
Publication of DK1140090T3 publication Critical patent/DK1140090T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00900025T 1999-01-07 2000-01-06 Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt DK1140090T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR99100005 1999-01-07
EP00900025A EP1140090B1 (en) 1999-01-07 2000-01-06 Use of phanquinone for the treatment or prevention of memory impairment
PCT/IB2000/000011 WO2000040244A1 (en) 1999-01-07 2000-01-06 Use of phanquinone for the treatment or prevention of memory impairment

Publications (1)

Publication Number Publication Date
DK1140090T3 true DK1140090T3 (da) 2005-04-18

Family

ID=10943706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900025T DK1140090T3 (da) 1999-01-07 2000-01-06 Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt

Country Status (17)

Country Link
US (1) US7030136B2 (da)
EP (1) EP1140090B1 (da)
JP (1) JP2002534386A (da)
AR (1) AR022215A1 (da)
AT (1) ATE285235T1 (da)
AU (1) AU1792200A (da)
BR (1) BR0008241A (da)
CA (1) CA2358487C (da)
DE (1) DE60016892T2 (da)
DK (1) DK1140090T3 (da)
ES (1) ES2234559T3 (da)
HK (1) HK1042039B (da)
IL (1) IL143903A (da)
PT (1) PT1140090E (da)
SI (1) SI1140090T1 (da)
TR (1) TR200101892T2 (da)
WO (1) WO2000040244A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69805305T2 (de) 1997-08-21 2002-12-05 P.N. Gerolymatos S.A., Kruoneri Verwendung von phanquinon zur behandlung von alzheimer's krankheit
WO2001082912A2 (en) * 2000-04-28 2001-11-08 Gerolymatos P N Sa TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING PHANQUINONE

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472257A (en) 1973-09-10 1977-05-04 Christiaens Sa A Derivative of 4-hydroxy-5-azacoumarin
PH25025A (en) * 1986-12-17 1991-01-28 Glaxo Group Ltd A method of treating dementia and other cognitive disorders using 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one
US5091391A (en) * 1990-08-16 1992-02-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of resisting neurodegenerative disorders
DE69227380T3 (de) 1991-11-12 2007-01-11 Prana Biotechnology Ltd., South Melbourne Verfahren zur bestimmung und behandlung von alzheimer-krankheit
US5866597A (en) * 1993-03-19 1999-02-02 Glaxo Wellcome Inc. Use of triazine compounds for the treatment of memory and learning disorders
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
AU1153097A (en) 1996-06-07 1998-01-05 Eisai Co. Ltd. Stable polymorphs of donepezil (1-benzyl-4-{(5,6-dimethoxy-1-indanon)-2-yl}methylpiperidine ) hydrochloride and process for production
HUP9903906A3 (en) * 1996-08-13 2001-01-29 Gerolymatos P N Sa Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP1007048A4 (en) 1997-03-11 2004-09-22 Gen Hospital Corp IDENTIFICATION OF AGENTS USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE
DE69805305T2 (de) * 1997-08-21 2002-12-05 P.N. Gerolymatos S.A., Kruoneri Verwendung von phanquinon zur behandlung von alzheimer's krankheit
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof

Also Published As

Publication number Publication date
ATE285235T1 (de) 2005-01-15
CA2358487A1 (en) 2000-07-13
DE60016892T2 (de) 2005-12-15
EP1140090B1 (en) 2004-12-22
PT1140090E (pt) 2005-05-31
HK1042039B (zh) 2005-07-29
WO2000040244A1 (en) 2000-07-13
JP2002534386A (ja) 2002-10-15
HK1042039A1 (en) 2002-08-02
US7030136B2 (en) 2006-04-18
DE60016892D1 (de) 2005-01-27
IL143903A0 (en) 2002-04-21
CA2358487C (en) 2008-11-18
BR0008241A (pt) 2001-10-30
TR200101892T2 (tr) 2001-11-21
AR022215A1 (es) 2002-09-04
US20030055078A1 (en) 2003-03-20
IL143903A (en) 2004-02-08
SI1140090T1 (en) 2005-06-30
EP1140090A1 (en) 2001-10-10
ES2234559T3 (es) 2005-07-01
AU1792200A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK2412368T3 (da) Sammensætning til behandling af ar
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
DK1411917T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DK199800837A (da) Anlæg til behandling af emner
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DK1218022T3 (da) Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba
DK1173179T3 (da) Anvendelse af saredutant og de farmaceutisk acceptable salte heraf til behandling eller forebyggelse af svær depressiv forstyrrelse
DK1534296T3 (da) Anvendelse af cilobradin eller de farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
DK1140090T3 (da) Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt
DE50006862D1 (de) Gerüsttragvorrichtung
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
DK1064014T3 (da) Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor
ATA70499A (de) Plattenförmiger sicherheitsbauteil
DK199900400U3 (da) System til beskyttelse af træværk
ATE256408T1 (de) Bauelement zur errichtung von regalen
DE50013770D1 (de) Fassaden-Gerüst